Pierre Geborek
affiliated with the university-
Acute alveolitis and sulphasalazine in rheumatoid arthritis
Pierre Geborek, M Monti, F Sandblad & Frank Wollheim, 1984, In : Clinical and Experimental Rheumatology. 2, 3, p. 279-280Research output: Contribution to journal › Article
-
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
Johan Karlsson, Martin Neovius, Jan-Åke Nilsson, Ingemar Petersson, Johan Bratt, Ronald F van Vollenhoven, Sofia Ernestam & Pierre Geborek, 2013, In : Annals of the Rheumatic Diseases. 72, 12, p. 1927-1933Research output: Contribution to journal › Article
-
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
R. F. van Vollenhoven, S. Ernestam, Pierre Geborek, Ingemar Petersson, L. Coster, E. Waltbrand, A. Zickert, J. Theander, A. Thorner, H. Hellstrom, A. Teleman, C. Dackhammar, F. Akre, K Forslind, L. Ljung, R. Oding, A. Chatzidionysiou, M. Wornert & J. Bratt, 2009, In : The Lancet. 374, 9688, p. 459-466Research output: Contribution to journal › Article
-
Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors
Meliha C Kapetanovic, Carmen Roseman, Göran Jönsson, Lennart Truedsson, Tore Saxne & Pierre Geborek, 2011, In : Arthritis and Rheumatism. 63, 12, p. 3723-3732Research output: Contribution to journal › Article
Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
Per Nived, Tore Saxne, Pierre Geborek, Thomas Mandl, Lillemor Skattum & Meliha C. Kapetanovic, 2018 Apr 5, In : BMC Rheumatology. 2, p. 1-7 12.Research output: Contribution to journal › Article
-
Antiproliferative effects on human peripheral blood mononuclear cells and inhibition of in vitro immunoglobulin synthesis by Podophyllotoxin (CPH86) and by semisynthetic lignan glycosides (CPH82)
Lennart Truedsson, Pierre Geborek & Gunnar Sturfelt, 1993, In : Clinical and Experimental Rheumatology. 11, 2, p. 179-182Research output: Contribution to journal › Article
-
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas:relative risks and time-trends in the Swedish Biologics Register
J Askling, E Baecklund, F Granath, Pierre Geborek, M. Fored, C Backlin, L Bertilsson, L Coster, L Jacobsson, S Rantapaa-Dahlqvist, Tore Saxne, R van Vollenhoven, L Klareskog & N Feltelius, 2009, In : Annals of the Rheumatic Diseases. 68, 5, p. 648-653 6 p.Research output: Contribution to journal › Article
-
A survey of spinal collateral actions of feline ventral spinocerebellar tract neurons.
Pierre Geborek, Elisabeth Nilsson, F Bolzoni & E Jankowska, 2012, In : European Journal of Neuroscience.Research output: Contribution to journal › Article
-
Behandling af reumatoid artrit med anti-tumornekrosefaktor-alpha-antistof. Individuel monitorering af biotilgaengelighed og immunogenicitet-- sekundaerpublikation
Klaus Bendtzen, Pierre Geborek, Morten Svenson, Lotta Larsson, Meliha C Kapetanovic & Tore Saxne, 2007, In : Ugeskrift for Laeger. 169, 5, p. 420-423Research output: Contribution to journal › Article
-
Biological vs Conventional Combination Treatment and Work Loss in Early Rheumatoid Arthritis A Randomized Trial
Jonas K. Eriksson, Martin Neovius, Johan Bratt, Ingemar Petersson, Ronald F. van Vollenhoven, Pierre Geborek & Sofia Ernestam, 2013, In : JAMA Internal Medicine. 173, 15, p. 1407-1414Research output: Contribution to journal › Article
Brief report: enhancement of patient recruitment in rheumatoid arthritis clinical trials using a multi-biomarker disease activity score as an inclusion criterion.
Ronald F van Vollenhoven, Rebecca Bolce, Karen Hambardzumyan, Saedis Saevarsdottir, Kristina Forslind, Ingemar Petersson, Eric H Sasso, C C Hwang, Oscar G Segurado & Pierre Geborek, 2015, In : Arthritis & Rheumatology. 67, 11, p. 2855-2860Research output: Contribution to journal › Article
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
Alf Kastbom, Kristina Forslind, Sofia Ernestam, Pierre Geborek, Johan Karlsson, Ingemar Petersson, Saedis Saevarsdottir, Lars Klareskog, Ronald F van Vollenhoven & Karin Lundberg, 2016, In : Annals of the Rheumatic Diseases. 75, 2, p. 356-361Research output: Contribution to journal › Article
-
Changing pattern in the prescription of biological treatment in rheumatoid arthritis. A 7-year follow-up of 1839 patients in southern Sweden
M. K. Soderlin & Pierre Geborek, 2008, In : Annals of the Rheumatic Diseases. 67, 1, p. 37-42Research output: Contribution to journal › Article
Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.
Robin Kahn, Elisabet Berthold, Birgitta Gullstrand, Tobias Schmidt, Fredrik Kahn, Pierre Geborek, Tore Saxne, Anders Bengtsson & Bengt Månsson, 2016, In : Acta paediatrica. 105, 4, p. 427-432Research output: Contribution to journal › Article
-
Clinical protocol for monitoring of targeted therapies in rheumatoid arthritis
Pierre Geborek & Tore Saxne, 2000, In : Rheumatology. 39, 10, p. 1159-1161Research output: Contribution to journal › Article
-
Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival
Irini Flouri, Theodora E. Markatseli, Paraskevi V. Voulgari, Kyriaki A. Boki, Ioannis Papadopoulos, Loukas Settas, Dimitrios Zisopoulos, Fotini N. Skopouli, Alexios Iliopoulos, George K. Bertsias, Pierre Geborek, Alexandros A. Drosos, Dimitrios T. Boumpas & Prodromos Sidiropoulos, 2014, In : Seminars in Arthritis and Rheumatism. 43, 4, p. 447-457Research output: Contribution to journal › Review article
Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients - baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
JOHAN KARLSSON WALLMAN, Meliha C Kapetanovic, Ingemar Petersson, Pierre Geborek & Lars Erik Kristensen, 2015, In : Arthritis Research and Therapy. 17, 1, 378.Research output: Contribution to journal › Article
Continuation of TNF blockade in patients with inflammatory rheumatic disease. An observational study on surgical site infections in 1,596 elective orthopedic and hand surgery procedures
Elisabet Berthold, Pierre Geborek & Anders Gülfe, 2013 Oct, In : Acta Orthopaedica. 84, 5, p. 495-501 7 p.Research output: Contribution to journal › Article
-
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial
Ronald F. van Vollenhoven, Pierre Geborek, Kristina Forslind, Kristina Albertsson, Sofia Ernestam, Ingemar Petersson, Katerina Chatzidionysiou & Johan Bratt, 2012, In : The Lancet. 379, 9827, p. 1712-1720Research output: Contribution to journal › Article
-
Cost-effectiveness of etanercept treatment in early active rheumatoid arthritis followed by dose adjustment.
Gisela Kobelt, Ingrid Lekander, Andrea Lang, Bernd Raffeiner, Costantino Botsios & Pierre Geborek, 2011, In : International Journal of Technology Assessment in Health Care. 27, 3, p. 193-200Research output: Contribution to journal › Article
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.
Jonas Eriksson, Johan Karlsson, Johan Bratt, Ingemar Petersson, Ronald van Vollenhoven, Sofia Ernestam, Pierre Geborek & Martin Neovius, 2015, In : Annals of the Rheumatic Diseases. 74, 6, p. 1094-1101Research output: Contribution to journal › Article
-
Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data
Gisela Kobelt, P. Lindgren & Pierre Geborek, 2009, In : Scandinavian Journal of Rheumatology. 38, 6, p. 409-418Research output: Contribution to journal › Article
-
Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden
JOHAN KARLSSON WALLMAN, Jonas K. Eriksson, Jan Åke Nilsson, Tor Olofsson, Lars Erik Kristensen, Martin Neovius & Pierre Geborek, 2016 Jul 1, In : Journal of Rheumatology. 43, 7, p. 1292-1299 8 p.Research output: Contribution to journal › Article
